NPPB and heart failure: Therefore, we sought to create a heart-failure-specific gene therapy system using the B-type natriuretic peptide (BNP) promoter [20], RNA polymerase II-mediated short hairpin RNA (shRNA) [21] and an AAV serotype 9 (AAV9) vector [22].